- Home
- LAES vs HQL Comparison
LAES vs HQL Comparison
Compare LAES & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- HQL
- Stock Information
- Founded
- LAES 2022
- HQL 1992
- Country
- LAES Switzerland
- HQL United States
- Employees
- LAES N/A
- HQL N/A
- Industry
- LAES Semiconductors
- HQL Investment Managers
- Sector
- LAES Technology
- HQL Finance
- Exchange
- LAES Nasdaq
- HQL Nasdaq
- Market Cap
- LAES 366.0M
- HQL 378.8M
- IPO Year
- LAES N/A
- HQL N/A
- Fundamental
- Price
- LAES $3.44
- HQL $13.92
- Analyst Decision
- LAES Strong Buy
- HQL
- Analyst Count
- LAES 1
- HQL 0
- Target Price
- LAES $6.00
- HQL N/A
- AVG Volume (30 Days)
- LAES 5.7M
- HQL 120.9K
- Earning Date
- LAES 09-25-2025
- HQL 01-01-0001
- Dividend Yield
- LAES N/A
- HQL 11.56%
- EPS Growth
- LAES N/A
- HQL N/A
- EPS
- LAES N/A
- HQL 0.79
- Revenue
- LAES $10,978,000.00
- HQL N/A
- Revenue This Year
- LAES N/A
- HQL N/A
- Revenue Next Year
- LAES N/A
- HQL N/A
- P/E Ratio
- LAES N/A
- HQL $17.08
- Revenue Growth
- LAES N/A
- HQL N/A
- 52 Week Low
- LAES $0.31
- HQL $11.34
- 52 Week High
- LAES $11.00
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- LAES 69.08
- HQL 51.80
- Support Level
- LAES $2.49
- HQL N/A
- Resistance Level
- LAES $3.54
- HQL $14.30
- Average True Range (ATR)
- LAES 0.20
- HQL 0.16
- MACD
- LAES 0.12
- HQL -0.55
- Stochastic Oscillator
- LAES 90.48
- HQL 96.80
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.